Skip to content

What is the difference between cortisone and dexamethasone?

4 min read

In 2020, an estimated 3.9 million people in the U.S. were prescribed dexamethasone, a potent corticosteroid [1.2.4]. Understanding what is the difference between cortisone and dexamethasone is crucial, as they are both anti-inflammatory steroids with distinct properties and applications.

Quick Summary

Cortisone is a short-acting prodrug that converts to cortisol, while dexamethasone is a potent, long-acting synthetic corticosteroid. Their primary differences lie in anti-inflammatory strength, duration, and clinical uses.

Key Points

  • Potency and Duration: Dexamethasone is a very potent (25-30x cortisol), long-acting steroid, while cortisone is a low-potency (0.8x cortisol), short-acting one [1.5.6, 1.2.2].

  • Mechanism of Action: Cortisone is an inactive prodrug that must be converted to active cortisol by the liver [1.3.5]. Dexamethasone is active upon administration [1.4.1].

  • Salt Retention: Cortisone has mineralocorticoid effects that can cause salt and water retention, whereas dexamethasone has virtually none [1.3.1, 1.5.6].

  • Clinical Uses: Cortisone is used for adrenal replacement and local injections [1.3.1]. Dexamethasone treats severe inflammation, allergies, and autoimmune diseases [1.6.6].

  • Half-Life: Cortisone has a biological half-life of 8-12 hours [1.5.6]. Dexamethasone has a much longer half-life of 36-54 hours [1.5.6].

  • Administration Forms: Dexamethasone is available in more forms, including oral, IV, and eye drops, compared to cortisone's oral and injectable forms [1.4.1, 1.2.5].

  • Side Effect Profile: Due to its high potency, long-term dexamethasone has a higher risk for systemic side effects like osteoporosis and adrenal suppression [1.2.1, 1.6.5].

In This Article

Understanding Corticosteroids: An Introduction

Corticosteroids, often simply called steroids, are a class of drugs that mimic the effects of cortisol, a hormone naturally produced by the adrenal glands [1.4.5, 1.3.2]. These powerful medications are widely used to relieve inflammation in various parts of the body by suppressing the immune system [1.6.5, 1.4.4]. They are prescribed for a multitude of conditions, including arthritis, asthma, allergies, skin conditions, and autoimmune diseases [1.6.7, 1.6.8]. Two commonly referenced corticosteroids are cortisone and dexamethasone. Although both belong to the glucocorticoid class, they possess significant differences in their chemical structure, potency, duration of action, and clinical applications [1.2.5, 1.3.2]. Understanding these distinctions is key to their safe and effective use in medicine.

What is Cortisone?

Cortisone itself is a biologically inactive substance, meaning it is a prodrug [1.3.5]. For it to become effective, the body must first metabolize it. This conversion process happens primarily in the liver, where the enzyme 11β-hydroxysteroid dehydrogenase type 1 transforms cortisone into cortisol (also known as hydrocortisone), the active glucocorticoid [1.3.1, 1.3.5, 1.3.6]. Because it requires this activation step, cortisone's effects are less direct than other steroids.

Cortisone is classified as a short-acting corticosteroid with a biological half-life of 8 to 12 hours [1.5.1, 1.5.6]. It possesses both glucocorticoid (anti-inflammatory) and mineralocorticoid (salt-retaining) properties [1.3.1]. Its anti-inflammatory potency is considered relatively low compared to synthetic derivatives; it is rated at 0.8 times the potency of cortisol [1.5.3, 1.5.6]. Due to its lower potency and the need for hepatic activation, oral cortisone is often used for replacement therapy in conditions like adrenal insufficiency, where the body does not produce enough of its own cortisol [1.3.1]. It is also administered via injection directly into joints or soft tissues to provide localized relief from pain and inflammation in conditions like bursitis and osteoarthritis [1.3.5, 1.2.5].

What is Dexamethasone?

Dexamethasone is a synthetic and highly potent corticosteroid that was first approved by the FDA in 1958 [1.2.4]. Unlike cortisone, it is biologically active upon administration and does not require conversion by the liver [1.4.1]. This gives it a more direct and powerful effect. Dexamethasone is classified as a long-acting corticosteroid, with a biological half-life of 36 to 54 hours, meaning its effects persist in the body for a much longer period [1.4.2, 1.5.6].

Its primary advantage is its high glucocorticoid potency and minimal mineralocorticoid activity [1.2.4]. Dexamethasone is approximately 25 to 30 times more potent than cortisol in its anti-inflammatory effects [1.2.2, 1.4.2, 1.5.6]. This makes it extremely effective for treating severe inflammatory conditions, autoimmune diseases, cerebral edema (swelling in the brain), severe allergies, and certain types of cancer like multiple myeloma [1.6.6, 1.6.5]. During the COVID-19 pandemic, dexamethasone was found to reduce mortality in hospitalized patients requiring respiratory support [1.4.2]. Its minimal effect on salt and water retention makes it preferable for conditions where fluid buildup is a concern [1.2.4].

Head-to-Head Comparison: Cortisone vs. Dexamethasone

The most critical distinctions between cortisone and dexamethasone are potency and duration of action. Dexamethasone is significantly stronger and lasts much longer in the body than cortisone. While cortisone has an anti-inflammatory potency rating of 0.8 relative to cortisol, dexamethasone's potency is around 30 [1.5.3, 1.5.6]. This vast difference means that much smaller doses of dexamethasone are needed to achieve a similar or greater anti-inflammatory effect [1.2.4].

Their mechanisms also differ. Cortisone is a prodrug requiring hepatic activation, making its onset and effectiveness dependent on liver function [1.3.7, 1.3.5]. Dexamethasone is directly active. Furthermore, cortisone has significant mineralocorticoid effects, which can lead to side effects like fluid retention and changes in blood pressure, whereas dexamethasone has virtually no such effects [1.5.6, 1.2.4].

These pharmacological profiles dictate their uses. Cortisone is suitable for hormone replacement and localized inflammation. Dexamethasone is reserved for severe, systemic inflammation and conditions where high-potency, long-lasting steroid action is required [1.6.6, 1.3.5].

Comparison Table

Feature Cortisone Dexamethasone
Classification Short-acting glucocorticoid [1.5.1] Long-acting glucocorticoid [1.5.2]
Type Prodrug (inactive until metabolized) [1.3.5] Active drug [1.4.1]
Potency Low (0.8x cortisol) [1.5.6] Very High (25-30x cortisol) [1.2.2, 1.5.6]
Biological Half-Life 8-12 hours [1.5.6] 36-54 hours [1.5.6]
Mineralocorticoid Effect Present (can cause salt/water retention) [1.3.1] Negligible [1.5.6, 1.2.4]
Primary Uses Adrenal insufficiency, localized joint inflammation [1.3.1, 1.3.5] Severe inflammation, allergies, cerebral edema, autoimmune disease, COVID-19 [1.6.6]
Administration Oral, intra-articular injection [1.3.5] Oral, intravenous, liquid, eye drops [1.4.1, 1.2.1]

Potential Side Effects

Both medications share the general side effects associated with corticosteroids, especially with long-term use. These can include increased appetite, weight gain, mood changes, insomnia, and high blood sugar [1.6.2, 1.6.3]. However, the risk profile for each differs slightly based on their properties.

With long-term use, dexamethasone carries a higher risk of more severe side effects due to its high potency and long duration of action. These include significant suppression of the body's natural steroid production (HPA axis suppression), osteoporosis (thinning of the bones), muscle weakness, and eye problems like cataracts and glaucoma [1.2.1, 1.6.5, 1.6.3]. Cortisone's mineralocorticoid effects can lead to fluid retention and high blood pressure [1.5.7]. Abruptly stopping either medication after prolonged use can lead to withdrawal symptoms and requires a gradual tapering of the dose [1.4.5].

Conclusion

In summary, while cortisone and dexamethasone are both valuable anti-inflammatory corticosteroids, they are not interchangeable. Cortisone is a short-acting, lower-potency prodrug with both glucocorticoid and mineralocorticoid effects, making it suitable for replacement therapy and treating local inflammation. Dexamethasone is a very potent, long-acting synthetic steroid with minimal mineralocorticoid activity, reserved for severe inflammatory and autoimmune conditions where powerful and sustained immunosuppression is necessary. The choice between them depends entirely on the specific medical condition, its severity, and the desired therapeutic outcome.


For more detailed information on corticosteroid properties, you can visit the National Adrenal Diseases Foundation [1.5.3].

Frequently Asked Questions

Yes, dexamethasone is significantly stronger than cortisone. It has an anti-inflammatory potency about 25 to 30 times that of cortisol, while cortisone's potency is slightly less than cortisol's [1.2.2, 1.5.6].

Dexamethasone is a long-acting steroid with a biological half-life of 36 to 54 hours. Cortisone is short-acting, with a biological half-life of only 8 to 12 hours [1.5.6].

A doctor might choose cortisone for conditions requiring lower-potency steroid action, such as for cortisol replacement therapy in adrenal insufficiency or for a localized anti-inflammatory effect via a joint injection [1.3.1, 1.3.5].

Topical application of cortisone is generally ineffective because it needs to be converted by the liver to its active form, cortisol. Direct application of cortisol (hydrocortisone) is used for skin conditions instead [1.3.7].

Long-term use of the high-potency dexamethasone can lead to serious side effects, including thinning of the bones (osteoporosis), adrenal gland suppression, increased risk of infection, eye problems like cataracts or glaucoma, and muscle weakness [1.6.5, 1.2.1].

Yes, cortisone has mineralocorticoid properties, which means it can cause the body to retain salt and water, potentially leading to swelling and increased blood pressure [1.3.1, 1.5.7].

Yes, studies have shown that dexamethasone can reduce mortality in hospitalized patients with severe COVID-19 who require oxygen or mechanical ventilation [1.4.2].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.